Cancer

Zhang, R., Wei, Z. Comment on: ‘Modelled impact of a multi-cancer early detection screening programme on cancer treatment in England’....

Newly published work in Neuro-Oncology spotlights a molecular vulnerability in glioblastoma (GBM), the most aggressive primary brain tumor. The study,...

Multiple myeloma (MM) treatment is entering a “de-escalation” era: clinicians aim to preserve deep, durable disease control while lowering long-term...

Insilico Medicine has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ISM6331, an...

Hospitals are not only places where childhood cancer is treated—they also generate records of earlier health encounters. A new population-based...

A new analysis published in British Journal of Cancer maps how oncology drug development in the UK has evolved over...

Stem cells in the Drosophila intestine continuously generate new cells, but their division must be precisely limited to preserve tissue...

Gastrointestinal cancers still claim a disproportionate share of global cancer burden—about one fifth of all cases and roughly one third...

Insilico Medicine has announced that first-in-human Phase 1 data for ISM6331, an AI-designed pan-TEAD inhibitor, has been accepted for a...

A new AI system from La Trobe University could help clinicians forecast relapse risk in patients with stage-two bowel cancer—potentially...